Keywords: یتیم 90; hPFS; hepatic progression-free survival; TARE; transarterial radioembolization; UM; uveal melanoma; 90Y; yttrium-90;
مقالات ISI یتیم 90 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: یتیم 90; TARE; transarterial radioembolization; 90Y; yttrium-90;
Keywords: یتیم 90; CI; confidence interval; FLR; future liver remnant; HCC; hepatocellular carcinoma; IQR; interquartile range; PVE; portal vein embolization; TLV; total liver volume; 90Y; yttrium-90;
Keywords: یتیم 90; AST; aspartate transaminase; CEA; carcinoembryonic antigen; CRC; colorectal cancer; NLR; neutrophil-lymphocyte ratio; OS; overall survival; RE; radioembolization; 90Y; yttrium-90;
Keywords: یتیم 90; Neuroendocrine tumor; Liver metastases; Yttrium-90; Radioembolization;
Keywords: یتیم 90; HCC; hepatocellular carcinoma; PVA; polyvinyl alcohol; RIPA; right inferior phrenic artery; 90Y; yttrium-90;
Keywords: یتیم 90; CI; confidence interval; CRLM; colorectal cancer liver metastases; 18F-FDG; 18F-fluorodeoxyglucose; HR; hazard ratio; LTD; longest tumor diameter; NTL; nontarget lesion; OS; overall survival; PET; positron emission tomography; RE; radioembolization; RECIS
Keywords: یتیم 90; Melanoma; Liver metastases; Yttrium-90; Radioembolization;
Keywords: یتیم 90; CI; confidence interval; mRECIST; modified Response Evaluation Criteria in Solid Tumors; RCC; renal cell carcinoma; 90Y; yttrium-90;
Keywords: یتیم 90; BCLC; Barcelona Clinic Liver Cancer; DEE; drug-eluting embolics; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: یتیم 90; ANOVA; analysis of variance; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma; ICC; intrahepatic cholangiocarcinoma; mCRC; metastatic colorectal carcinoma; SHAPD; systemic-hepatic artery pressure difference; SIS; Surefire Infusion System; TARE; tr
Keywords: یتیم 90; ALBI; albumin-bilirubin; BCLC; Barcelona Liver Clinic Cancer; CI; confidence interval; CPC; Child-Pugh class; HCC; hepatocellular carcinoma; N/A; not applicable; PALBI; platelet-bilirubin-albumin; 90Y; yttrium-90;
Keywords: یتیم 90; CI; confidence interval; HCC; hepatocellular carcinoma; HR; hazard ratio; IPTW; inverse probability of treatment weight; IQR; interquartile range; OLT; orthotopic liver transplantation; OS; overall survival; PFS; progression-free survival; PS; propensity
Keywords: یتیم 90; Radioembolization; Microsphere; Yttrium-90; Neuroendocrine tumor; Liver metastasis; Unresectable
Keywords: یتیم 90; ALBI; albumin-bilirubin; BCLC; Barcelona Clinic Liver Cancer; C-P; Child-Pugh; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; HCC; hepatocellular carcinoma; OS; median overall survival; 90Y; yttrium-90;
Keywords: یتیم 90; Ang-2; angiopoietin-2; HCC; hepatocellular carcinoma; IL; interleukin; OLT; orthotopic liver transplantation; PDGF; platelet-derived growth factor; VEGF; vascular endothelial growth factor; 90Y; yttrium-90;
Keywords: یتیم 90; AST; aspartate aminotransferase; BSA; body surface area; CI; confidence interval; CP; Child-Pugh; HCC; hepatocellular carcinoma; HR; hazard ratio; OS; overall survival; PVT; portal vein thrombosis; TTP; time to progression; TTT; time to toxicity; 90Y; ytt
Keywords: یتیم 90; Hepatic arterial therapy (HAT); Chemoembolization; Hepatic artery infusion (HAI); Colorectal liver metastases; Surgical resection; Yttrium-90; Drug-eluting beads (DEB);
Keywords: یتیم 90; AC; activity concentration; BSA; body surface area; IQR; interquartile range; LLS; liver-lung shunt; LV; liver volume; RE; radioembolization; RF; reduction factor; 99mTc-MAA; technetium-99m macroaggregated albumin; 90Y; yttrium-90;
Keywords: یتیم 90; GM; geometic mean; HCC; hepatocellular carcinoma; HV; hepatic vein; LSF; lung shunt fraction; MAA; macroaggregated albumin; OR; odds ratio; PV; portal vein; 99mTc; technetium-99m; 90Y; yttrium-90;
Keywords: یتیم 90; ID; inner diameter; NRC; Nuclear Regulatory Commission; RE; radioembolization; 90Y; yttrium-90;
Keywords: یتیم 90; HCC; hepatocellular carcinoma; HPSF; hepatopulmonary shunt fraction; HVTT; hepatic vein tumor thrombus; MIRD; medical internal radiation dose; PVA; polyvinyl alcohol; PVTT; portal vein tumor thrombus; RE; radioembolization; RP; radiation pneumonitis; 99mT
Keywords: یتیم 90; HA; hepatic arterial; SIRT; selective internal radiation therapy; 99mTc-MAA; technetium-99m albumin aggregated; 90Y; yttrium-90;
Keywords: یتیم 90; Radioembolization; Yttrium-90; Transarterial chemoembolization; Drug eluting beads
Keywords: یتیم 90; AFP; α-fetoprotein; AUC; area under the curve; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; IL; interleukin; mRECIST; modified Response Evaluation Criteria In Solid Tumors; NLR; neutrophil-to-lymphocyte ratio; RE; radioembolization
Keywords: یتیم 90; DSA; digital subtraction angiography; LSF; lung shunt fraction; MIRD; medical internal radiation dose; SPECT; single photon emission computed tomography; 99mTc-MAA; technetium-99m macroaggregated albumin; 90Y; yttrium-90;
Keywords: یتیم 90; Radioembolization; Hepatocellular carcinoma; HCC; Yttrium-90; Survival; Morbidity;
Keywords: یتیم 90; CI; confidence interval; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; PVT; portal vein thrombosis; TIPS; transjugular intrahepatic portosystemic shunt; TTP; time to progression; 90Y; yttrium-90;
Keywords: یتیم 90; Breast neoplasm; computed tomography; liver metastasis; RECIST; Yttrium-90;
Keywords: یتیم 90; BSA; body surface area; CEA; carcinoembryonic antigen; DWL; whole-liver absorbed dose; mCRC; metastatic colorectal carcinoma; RECIST; Response Evaluation Criteria in Solid Tumors; REILD; radioembolization-induced liver disease; SPECT; single photon emissi
Keywords: یتیم 90; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; 90Y; yttrium-90;
Keywords: یتیم 90; aFGF; acidic fibroblast growth factor; Ang-2; angiopoietin-2; bFGF; basic fibroblast growth factor; Conc; concentration; FGFR; fibroblast growth factor receptor; G-CSF; granulocyte colony-stimulating factor; GM-CSF; granulocyte-macrophage colony-stimulati
Keywords: یتیم 90; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; PVT; portal vein thrombosis; ROI; region of interest; SPECT; single photon emission computed tomography; 99mTc-MAA; technetium-99m macroaggregated albumin; TD; t
Patient Radiation Exposure in Transradial versus Transfemoral Yttrium-90 Radioembolization: A Retrospective Propensity Score-Matched Analysis
Keywords: یتیم 90; AK; air kerma; DAP; dose-area product; FT; fluoroscopy time; PRE; patient radiation exposure; TARE; transarterial yttrium-90 radioembolization; TFA; transfemoral access; TRA; transradial access; 90Y; yttrium-90;
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study
Keywords: یتیم 90; CA; cancer antigen; CI; confidence interval; ECOG; Eastern Cooperative Oncology Group; ICC; intrahepatic cholangiocarcinoma; INR; international normalized ratio; MELD; Model for End-Stage Liver Disease; OS; overall survival; RECIST; Response Evaluation Cr
Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases
Keywords: یتیم 90; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; HR; hazard ratio; NET; neuroendocrine tumor; TARE; transarterial radioembolization; 90Y; yttrium-90;
Controlling injectability and in vivo stability of thermogelling copolymers for delivery of yttrium-90 through intra-tumoral injection for potential brachytherapy
Keywords: یتیم 90; Thermogelling copolymers; Injectability; Intra-tumoral injection; Yttrium-90; Radionuclide delivery; Brachytherapy;
Long-Term Hepatotoxicity of Yttrium-90 Radioembolization as Treatment of Metastatic Neuroendocrine Tumor to the Liver
Keywords: یتیم 90; mNET; metastatic neuroendocrine tumor; 90Y; yttrium-90;
Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT
Keywords: یتیم 90; CR; complete response; HCC; hepatocellular carcinoma; LSF; lung shunt fraction; mRECIST; Modified Response Evaluation Criteria in Solid Tumors; NET; neuroendocrine tumor; PD; progressive disease; PR; partial response; SD; stable disease; SPECT; single pho
Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT
Keywords: یتیم 90; AD; absorbed dose; CI; confidence interval; HCC; hepatocellular carcinoma; MAA; macroaggregated albumin; mRECIST; modified RECIST; PET; positron emission tomography; RDC; reproducibility coefficient; RE; radioembolization; RECIST; Response Evaluation Crit
General ReviewPeptide receptor radionuclide therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): From literature to practiceRadiothérapie interne vectorisée par les peptides des tumeurs neuroendocrines gastro-entéro-pancréatiques (TNE-G
Keywords: یتیم 90; Neuroendocrine tumors; PRRT; 177Lu-octreotate; Somatostatin analogs; Chemotherapy; Targeted therapy; Yttrium-90; Tumeurs neuroendocrines; Radiothérapie interne vectorisée; 177Lu-octreotate; Somatostatine; Chimiothérapie; Thérapies ciblées; Yttrium-90
Collimator and energy window optimization for 90Y bremsstrahlung SPECT imaging: A SIMIND Monte Carlo study
Keywords: یتیم 90; Bremsstrahlung imaging; Energy window; Image contrast; Medium-energy collimator; Monte Carlo simulation; Radioembolization; SPECT; Yttrium-90
Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings
Keywords: یتیم 90; cholecystectomy; gallbladder; interventional oncology; radioembolization; yttrium-90
Radioembolization following Liver Resection: Safety and Dosing Considerations
Keywords: یتیم 90; BSA; body surface area; CI; confidence interval; RE; radioembolization; REILD; radioembolization-induced liver disease; 90Y; yttrium-90;
Calculation of tumour and normal tissue biological effective dose in 90Y liver radioembolization with different dosimetric methods
Keywords: یتیم 90; Yttrium-90; BED; Dosimetry; Microspheres;
Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma
Keywords: یتیم 90; BCLC; Barcelona Clinic Liver Cancer; HCC; hepatocellular carcinoma; TARE; transarterial radioembolization; 90Y; yttrium-90;
Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging for Prediction of Early Arterial Blood Flow Stasis in Radioembolization of Breast Cancer Liver Metastases
Keywords: یتیم 90; ADC; apparent diffusion coefficient; Dâ²; estimated true diffusion coefficient; DWI; diffusion-weighted imaging; fâ²; estimated perfusion fraction; IVIM; intravoxel incoherent motion; LdBM; liver dominant breast metastases; ROC; receiver operating chara
Bariatric Radioembolization: A Pilot Study on Technical Feasibility and Safety in a Porcine Model
Keywords: یتیم 90; BAE; bariatric arterial embolization; EBRT; external-beam radiation therapy; GI; gastrointestinal; H&E; hematoxylin-eosin; HPF; high-power field; LGA; left gastric artery; MAA; macroaggregated albumin; NTE; nontarget embolization; TARE; transarterial radi
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal 90Y
Keywords: یتیم 90; Yttrium-90; Trastuzumab; CHX-A″-DTPA; H4octapa; Radiometal; Radioimmunotherapy
Safety and Efficacy of Radioembolization in Elderly (⥠70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer
Keywords: یتیم 90; Advanced; Brachytherapy; Metastases; SIRT; Yttrium-90;